In this session, you will receive the most important cardiology updates from 2018-2019, including trial evidence for dietary supplements in the prevention of cardiovascular disease and new information about the blood cholesterol guidelines. The session will also provide advice on how to differentiate between opportunistic and systematic screening for atrial fibrillation as well as identify ways to conduct this screening in practice. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 8th 2020 and they are subject to change as new information is published.
National lipid expert faculty will discuss the incidence of and diagnostic criteria for statin intolerance, explain the mechanistic rationale for lowering LDL-C through nonstatin therapies, explore novel targets and treatment pathways, and apply the 2018 AHA/ACC Cardiology Cholesterol Guidelines. Learners will have gain practical clinical perspectives during expert case study discussions, including how new treatment options may fit into the current therapeutic landscape.
Triglycerides and their management have received a great deal of publicity recently due to clinical trial results. Join Dr. Ty Gluckman as he reviews the risks associated with hypertriglyceridemia, discusses available therapeutic options to lower triglycerides, and reconciles the finding of the REDUCE-IT and the STRENGTH trials.
Hypercholesteremia is highly prevalent in the U.S. and strongly associated with cardiovascular morbidity and mortality. Yet, only about 55% of U.S. adults appropriate for cholesterol lowering therapy are currently taking it. What do primary care providers need to know to improve the care of the many individuals with hypercholesterolemia that you see daily in clinical practice? Join Dr. Ty Gluckman in this webcast to find out.
Hypercholesteremia is highly prevalent in the U.S. and strongly associated with cardiovascular morbidity and mortality. Yet, only about 55% of U.S. adults appropriate for cholesterol lowering therapy are currently taking it. What do primary care providers need to know to improve the care of the many individuals with hypercholesterolemia that you see daily in clinical practice? Join Dr. Ty Gluckman for part 2 of this webcast series to find out.
Effective Tool or Diet Fad? Can Intermittent Fasting Decrease Weight and Improve Cardiovascular Markers? - Frankly Speaking EP 165
Guest: Susan Feeney, DNP, FNP-BCMusic Credit: Richard Onorato
Obesity, dyslipidemia, and hypertension are significant challenges to public health and impact a growing number of Americans. Weight loss and dietary changes are effective in preventing CVD and DMII and reducing cardiometabolic complications, but can be difficult for many people. Growing evidence supports the use of timed fasting to promote weight loss and reduce these complications. Join us as we discuss a recent study that shows promising data regarding a 10-hour feeding window and improved CV markers.
Guest: Robert A. Baldor, MD, FAAFPMusic Credit: Richard Onorato
Various organizations develop guidelines to assist with patient care. This episode will review the most significant changes to the U.S. Department of Veterans Affairs and U.S. Department of Defense (VA/DoD) Clinical Practice Guidelines for the Management of Dyslipidemia for Cardiovascular Disease Risk Reduction.